Kozberg MG, Perosa V, Gurol ME, van Veluw SJ. A practical approach to the management of cerebral amyloid angiopathy. Int J Stroke. 2021;16(4):356–69.

Article  PubMed  Google Scholar 

Greenberg SM, Gurol ME, Rosand J, Smith EE. Amyloid angiopathy-related vascular cognitive impairment. Stroke. 2004;35(11 Suppl 1):2616–9.

Article  PubMed  Google Scholar 

Durrani R, Wang M, Cox E, Irving E, Saad F, McCreary CR, et al. Mediators of cognitive impairment in cerebral amyloid angiopathy. Int J Stroke. 2023;18(1):78–84.

Article  PubMed  Google Scholar 

Jellinger KA. Alzheimer disease and cerebrovascular pathology: an update. J Neural Transm (Vienna). 2002;109(5–6):813–36.

Article  CAS  PubMed  Google Scholar 

Chwalisz BK. Cerebral amyloid angiopathy and related inflammatory disorders. J Neurol Sci. 2021;424: 117425.

Article  CAS  PubMed  Google Scholar 

•• Antolini L, DiFrancesco JC, Zedde M, Basso G, Arighi A, Shima A, et al. Spontaneous ARIA-like events in cerebral amyloid angiopathy-related inflammation: a multicenter prospective longitudinal cohort study. Neurology. 2021;97(18):e1809-e22. The largest published prospective cohort study of inflammatory CAA.

• Grangeon L, Quesney G, Verdalle-Cazes M, Coulette S, Renard D, Wacongne A, et al. Different clinical outcomes between cerebral amyloid angiopathy-related inflammation and non-inflammatory form. J Neurol. 2022;269(9):4972–84. A multicenter retrospective cohort study, the largest such observational study comparing inflammatory CAA outcomes to those of age- and sex-matched controls with non-inflammatory CAA.

•• Theodorou A, Palaiodimou L, Malhotra K, Zompola C, Katsanos AH, Shoamanesh A, et al. Clinical, neuroimaging, and genetic markers in cerebral amyloid angiopathy-related inflammation: a systematic review and meta-analysis. Stroke. 2023;54(1):178–88. A comprehensive systematic review of existing cohort studies and case series, providing our most accurate estimates to date of the prevalence of various clinical, imaging, and genetic biomarkers.

Charidimou A, Boulouis G, Frosch MP, Baron JC, Pasi M, Albucher JF, et al. The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI-neuropathology diagnostic accuracy study. Lancet Neurol. 2022;21(8):714–25.

Auriel E, Charidimou A, Gurol ME, Ni J, Van Etten ES, Martinez-Ramirez S, et al. Validation of clinicoradiological criteria for the diagnosis of cerebral amyloid angiopathy-related inflammation. JAMA Neurol. 2016;73(2):197–202.

Article  PubMed  Google Scholar 

Salvarani C, Morris JM, Giannini C, Brown RD Jr, Christianson T, Hunder GG. Imaging findings of cerebral amyloid angiopathy, abeta-related angiitis (ABRA), and cerebral amyloid angiopathy-related inflammation: a single-institution 25-year experience. Medicine (Baltimore). 2016;95(20):e3613.

Article  CAS  PubMed  Google Scholar 

Raghavan P, Looby S, Bourne TD, Wintermark M. Cerebral amyloid angiopathy-related inflammation: a potentially reversible cause of dementia with characteristic imaging findings. J Neuroradiol. 2016;43(1):11–7.

Article  PubMed  Google Scholar 

Chung KK, Anderson NE, Hutchinson D, Synek B, Barber PA. Cerebral amyloid angiopathy related inflammation: three case reports and a review. J Neurol Neurosurg Psychiatry. 2011;82(1):20–6.

Article  PubMed  Google Scholar 

Wu JJ, Yao M, Ni J. Cerebral amyloid angiopathy-related inflammation: current status and future implications. Chin Med J (Engl). 2021;134(6):646–54.

Article  CAS  PubMed  Google Scholar 

Corovic A, Kelly S, Markus HS. Cerebral amyloid angiopathy associated with inflammation: a systematic review of clinical and imaging features and outcome. Int J Stroke. 2018;13(3):257–67.

Article  PubMed  Google Scholar 

•• Regenhardt RW, Thon JM, Das AS, Thon OR, Charidimou A, Viswanathan A, et al. Association between immunosuppressive treatment and outcomes of cerebral amyloid angiopathy-related inflammation. JAMA Neurol. 2020;77(10):1261–9. A retrospective cohort study providing one of the first systematic investigations of the association between immunosuppression treatments and improved outcomes in inflammatory CAA.

Danve A, Grafe M, Deodhar A. Amyloid beta-related angiitis–a case report and comprehensive review of literature of 94 cases. Semin Arthritis Rheum. 2014;44(1):86–92.

Article  PubMed  Google Scholar 

Tabaee Damavandi P, Storti B, Fabin N, Bianchi E, Ferrarese C, DiFrancesco JC. Epilepsy in cerebral amyloid angiopathy: an observational retrospective study of a large population. Epilepsia. 2023;64(2):500–10.

Article  CAS  PubMed  Google Scholar 

Eng JA, Frosch MP, Choi K, Rebeck GW, Greenberg SM. Clinical manifestations of cerebral amyloid angiopathy-related inflammation. Ann Neurol. 2004;55(2):250–6.

Article  PubMed  Google Scholar 

Moussaddy A, Levy A, Strbian D, Sundararajan S, Berthelet F, Lanthier S. Inflammatory cerebral amyloid angiopathy, amyloid-beta-related angiitis, and primary angiitis of the central nervous system: similarities and differences. Stroke. 2015;46(9):e210–3.

Article  PubMed  Google Scholar 

Singh B, Lavezo J, Gavito-Higueroa J, Ahmed F, Narasimhan S, Brar S, et al. Updated outlook of cerebral amyloid angiopathy and inflammatory subtypes: pathophysiology, clinical manifestations, diagnosis and management. J Alzheimers Dis Rep. 2022;6(1):627–39.

Article  PubMed  PubMed Central  Google Scholar 

Alokley AA, Alshamrani FJ, Alabbas FM, Nazish S. When brain biopsy solves the dilemma of diagnosing atypical cerebral amyoild angiopathy: a case report. Am J Case Rep. 2021;22: e933869.

Article  PubMed  PubMed Central  Google Scholar 

Kinnecom C, Lev MH, Wendell L, Smith EE, Rosand J, Frosch MP, et al. Course of cerebral amyloid angiopathy-related inflammation. Neurology. 2007;68(17):1411–6.

Article  CAS  PubMed  Google Scholar 

Jack CR Jr, Bennett DA, Blennow K, Carrillo MC, Feldman HH, Frisoni GB, et al. A/T/N: an unbiased descriptive classification scheme for Alzheimer disease biomarkers. Neurology. 2016;87(5):539–47.

Article  CAS  PubMed  PubMed Central  Google Scholar 

International CAA and AD Biomarkers International Network. 2023. https://sites.google.com/site/icabinternationalnetwork.

Coulette S, Renard D, Lehmann S, Raposo N, Arquizan C, Charif M, et al. A clinico-radiological study of cerebral amyloid angiopathy-related inflammation. Cerebrovasc Dis. 2019;48(1–2):38–44.

Article  PubMed  Google Scholar 

Verbeek MM, Kremer BP, Rikkert MO, Van Domburg PH, Skehan ME, Greenberg SM. Cerebrospinal fluid amyloid beta(40) is decreased in cerebral amyloid angiopathy. Ann Neurol. 2009;66(2):245–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

DiFrancesco JC, Brioschi M, Brighina L, Ruffmann C, Saracchi E, Costantino G, et al. Anti-Abeta autoantibodies in the CSF of a patient with CAA-related inflammation: a case report. Neurology. 2011;76(9):842–4.

Article  CAS  PubMed  Google Scholar 

•• Piazza F, Greenberg SM, Savoiardo M, Gardinetti M, Chiapparini L, Raicher I, et al. Anti-amyloid beta autoantibodies in cerebral amyloid angiopathy-related inflammation: implications for amyloid-modifying therapies. Ann Neurol. 2013;73(4):449–58. Case series of four patients with inflammatory CAA that demonstrated reduction in anti-Aβ autoantibodies after immunosuppression treatment, which correlated with clinical and radiographic improvement and reduction in microglial activation as measured with 11C-PK11195 PET imaging.

Piazza F, Caminiti SP, Zedde M, Presotto L, DiFrancesco JC, Pascarella R, et al. Association of microglial activation with spontaneous ARIA-E and CSF levels of anti-abeta autoantibodies. Neurology. 2022;99(12):e1265–77.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jack CR Jr. Advances in Alzheimer’s disease research over the past two decades. Lancet Neurol. 2022;21(10):866–9.

Article  PubMed  Google Scholar 

Leurent C, Goodman JA, Zhang Y, He P, Polimeni JR, Gurol ME, et al. Immunotherapy with ponezumab for probable cerebral amyloid angiopathy. Ann Clin Transl Neurol. 2019;6(4):795–806.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Greenberg SM, Rosand J, Schneider AT, Creed Pettigrew L, Gandy SE, Rovner B, et al. A phase 2 study of tramiprosate for cerebral amyloid angiopathy. Alzheimer Dis Assoc Disord. 2006;20(4):269–74.

Article  CAS  PubMed  Google Scholar 

Salloway S, Chalkias S, Barkhof F, Burkett P, Barakos J, Purcell D, et al. Amyloid-related imaging abnormalities in 2 phase 3 studies evaluating aducanumab in patients with early Alzheimer disease. JAMA Neurol. 2022;79(1):13–21.

Article  PubMed  Google Scholar 

Sperling RA, Jack CR Jr, Black SE, Frosch MP, Greenberg SM, Hyman BT, et al. Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: recommendations from the Alzheimer’s Association Research Roundtable Workgroup. Alzheimers Dement. 2011;7(4):367–85.

Article  PubMed  PubMed Central  Google Scholar